Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Cyrille J. Bonhomme"'
Autor:
Prasad S. Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, Ashish Bavdekar, Madhu Gupta, Praveen Kulkarni, B.S. Garg, Nithya J. Gogtay, Muralidhar Tambe, Sanjay Lalwani, Kiranjit Singh, Renuka Munshi, Sushant Meshram, T.S. Selvavinayagam, Krishna Pandey, Devi Madhavi Bhimarasetty, S.R. Ramakrishnan, Chetanraj Bhamare, Abhijeet Dharmadhikari, Chandrashekhar Budhawant, Cyrille J. Bonhomme, Madhuri Thakar, Swarali N. Kurle, Elizabeth J. Kelly, Manish Gautam, Nivedita Gupta, Samiran Panda, Balram Bhargava, Cyrus S. Poonawalla, Umesh Shaligram, Dhananjay Kapse, Bhagwat Gunale
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTAZD1222 (ChAdOx1 nCoV-19) is a replication-deficient adenoviral vectored coronavirus disease-19 (COVID-19) vaccine that is manufactured as SII-ChAdOx1 nCoV-19 by the Serum Institute of India Pvt Ltd following technology transfer from Oxford U
Externí odkaz:
https://doaj.org/article/8b89a3e8f8ac470894c80a7c06493aa6
Autor:
Deidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, Kevin M Tuffy, Tina Green, Rebecca Greway, Brittany Fikes, Cyrille J Bonhomme, Mark T Esser, Elizabeth J Kelly
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 4, Pp n/a-n/a (2022)
Abstract Objectives Robust, quantitative serology assays are required to accurately measure antibody levels following vaccination and natural infection. We present validation of a quantitative, multiplex, SARS‐CoV‐2, electrochemiluminescent (ECL)
Externí odkaz:
https://doaj.org/article/185998943a9c4bd88730c7fd662763ef
Autor:
Marie E Bonhomme, Cyrille J Bonhomme, Lisa Strelow, Atul Chaudhari, Adrienne Howlett, Carl Breidenbach, Jack Hester, Christopher Hammond, Michéal Fuzy, Laura Harvey, Vanessa Swanner, Jeymie Ellis, Rebecca R Greway, Victoria A Pisciella, Tina Green, Lisa Kierstead
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0262922 (2022)
To enable benchmarking of immunogenicity between candidate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines, there is a need for standardized, validated immunogenicity assays. In this article, we report the design and criteria us
Externí odkaz:
https://doaj.org/article/2a27a12a41f240d3b87164947c4f0504
Autor:
Joseph M. Antonello, Rebecca Greway, Tina Green, Polly De Gorguette D'Argoeuves, Adrienne H Howlett, Yuhua Zhang, Cyrille J Bonhomme, Katrina M. Nolan, Rocio D Murphy, David Goldblatt
Publikováno v:
Bioanalysis. 12:1363-1375
Aim: To re-optimize the pneumococcal (Pn) electrochemiluminescence (ECL) assay and to validate and bridge the enhanced assay to the WHO ELISA, to support the Phase III clinical trial program for V114, a 15-valent Pn conjugate vaccine. Materials & met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eee427d50cc414a25552a53a65f37b5c
https://doi.org/10.4155/bio-2020-0023
https://doi.org/10.4155/bio-2020-0023
Autor:
Deidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, Kevin M Tuffy, Tina Green, Rebecca Greway, Brittany Fikes, Cyrille J Bonhomme, Mark T Esser, Elizabeth J Kelly
Publikováno v:
Clinicaltranslational immunology. 11(4)
Robust, quantitative serology assays are required to accurately measure antibody levels following vaccination and natural infection. We present validation of a quantitative, multiplex, SARS-CoV-2, electrochemiluminescent (ECL) serology assay; show co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95124edae84d497c020936b9554e9c1
https://pubmed.ncbi.nlm.nih.gov/35495877
https://pubmed.ncbi.nlm.nih.gov/35495877
Publikováno v:
mBio, Vol 5, Iss 6 (2014)
ABSTRACT The rodent arenavirus glycoprotein complex encodes a stable signal peptide (SSP) that is an essential structural component of mature virions. The SSP, GP1, and GP2 subunits of the trimeric glycoprotein complex noncovalently interact to stud
Externí odkaz:
https://doaj.org/article/a35c8db8378e4946848ba9c386a29fd9
Autor:
Prasad S. Kulkarni, Chandrasekaran Padmapriyadarshini, Johan Vekemans, Ashish Bavdekar, Madhu Gupta, Praveen Kulkarni, B. S. Garg, Nithya J. Gogtay, Muralidhar Tambe, Sanjay Lalwani, Kiranjit Singh, Renuka Munshi, Sushant Meshram, T. S. Selvavinayagam, Krishna Pandey, Devi Madhavi Bhimarasetty, S. R. Ramakrishnan, Chetanraj Bhamare, Abhijeet Dharmadhikari, Rajeev Vadakkedath, Cyrille J. Bonhomme, Madhuri Thakar, Swarali N. Kurle, Elizabeth J. Kelly, Manish Gautam, Nivedita Gupta, Samiran Panda, Balram Bhargava, Umesh Shaligram, Dhananjay Kapse, Bhagwat Gunale, COVISHIELD Study Group
Publikováno v:
SSRN Electronic Journal.
Background: ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (SII-ChAdOx1 nCoV-19), manufactured in India at Serum Institute of India Pvt Ltd (SIIPL) after technology transfer from AstraZeneca, was evaluated in this phase 2/3 immunobridging study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::601162143fc3340f94bb80b5413af048
https://doi.org/10.2139/ssrn.3901791
https://doi.org/10.2139/ssrn.3901791
Autor:
Cyrille J Bonhomme, Kristeene A Knopp, Lydia H Bederka, Megan M Angelini, Michael J Buchmeier
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e53273 (2013)
The glycoprotein (GP) of arenaviruses is glycosylated at 11 conserved N-glycosylation sites. We constructed recombinant lymphocytic choriomeningitis virus (rLCMV) featuring either additions or deletions of these N-glycans to investigate their role in
Externí odkaz:
https://doaj.org/article/5fd173fa835745248c21635524a37c35
Autor:
Chetanraj Bhamare, S. R. Ramakrishnan, Madhu Gupta, Prasad S. Kulkarni, Nithya J Gogtay, Bishan S Garg, Madhuri Thakar, Sanjay Lalwani, Swarali N. Kurle, Dhananjay Kapse, Cyrille J. Bonhomme, Devi Madhavi Bhimarasetty, Renuka Munshi, Sushant H. Meshram, Johan Vekemans, Praveen Kulkarni, Bhagwat Gunale, Abhijeet Dharmadhikari, Manish Gautam, Krishna Pandey, Muralidhar Tambe, Chandrasekaran Padmapriyadarsini, Elizabeth J. Kelly, Ashish Bavdekar, Kiranjit Singh, Umesh Shaligram, Nivedita Gupta, Samiran Panda, T. S. Selvavinayagam, Rajeev Vadakkedath, Balram Bhargava
Publikováno v:
EClinicalMedicine
Background This phase 2/3 immunobridging study evaluated the safety and immunogenicity of the ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant) (SII-ChAdOx1 nCoV-19), manufactured in India at the Serum Institute of India Pvt Ltd (SIIPL), following te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3883635d74720a8cfb48a4242df5105d
https://doi.org/10.1016/j.eclinm.2021.101218
https://doi.org/10.1016/j.eclinm.2021.101218
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 27:959-968
Whipple's disease is a systemic chronic infection caused by Tropheryma whipplei. Asymptomatic people may carry T. whipplei in their digestive tract and this can be determined by PCR, making serological diagnosis useful to distinguish between carriers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::885ebe3ebf30440da361dca2a881e5dd
https://doi.org/10.1007/s10096-008-0528-0
https://doi.org/10.1007/s10096-008-0528-0